Clinical Trial Update: HBsAb Response After HBV Vaccination in Chronic Hepatitis B Patients Who Have Lost HBsAg [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating hepatitis B surface antibody response after HBV vaccination in chronic hepatitis B patients who have lost HBsAg.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Snippet

Sponsor: Mahidol University | Conditions: Chronic Hepatitis B, HBsAg, Hepatitis B Vaccine | Phase 3 | Status: UNKNOWN